When does Eidos Therapeutics, Inc. report earnings?
Eidos Therapeutics, Inc. reports earnings every quartal, last Eidos Therapeutics, Inc. earnings report date was 30/09/2019.
How much is Eidos Therapeutics, Inc. earnings per share?
Eidos Therapeutics, Inc. estimated earnings per share was 0.18 $ last time.
When is Eidos Therapeutics, Inc. next earnings report?
Next Eidos Therapeutics, Inc. earnings call will be in December 2024.
Eidos Therapeutics, Inc. earnings per share of a financial organization is a calculated indicator of the success of a company, tied to the value of the organization itself. Earnings per share - calculated value: the total profit for the reporting period is divided by the number of existing shares. Obviously, Eidos Therapeutics, Inc. earnings per share is a variable indicator for a specific financial period. Profit of Eidos Therapeutics, Inc. - the entire profit of the company in the reporting period.
|
Eidos Therapeutics, Inc. earnings report
Profits for the entire company Eidos Therapeutics, Inc. is more important to managing managers than shareholders of the company. Shareholders are more interested in earnings per share. It primarily affects the received dividends on shares. The date of the Eidos Therapeutics, Inc. profit report is set by the organization’s management. All dates of Eidos Therapeutics, Inc. profit reports are shown in our schedule and our table.
|
Eidos Therapeutics, Inc. quarterly earnings
Earnings per share Eidos Therapeutics, Inc. is calculated by dividing the company's profit by the number of its shares. Earnings per share of Eidos Therapeutics, Inc. is determined for a fixed financial period and corresponds to the outputs of the financial statements on the company's profit. Eidos Therapeutics, Inc. earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). Quarterly profit Eidos Therapeutics, Inc. is the most common type of financial report for financial analytics.
|
|
EIDX earnings date
|
Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
|
Change for a year %
|
|
30/09/2019 |
0.18 USD |
-8.89% ↓ |
|
30/06/2019 |
-0.39 USD |
-41.88% ↓ |
|
31/03/2019 |
-0.32 USD |
- |
|
31/12/2018 |
-0.27 USD |
- |
|
30/09/2018 |
-0.29 USD |
- |
|
30/06/2018 |
-1.38 USD |
- |
Eidos Therapeutics, Inc. quarterly earnings per share is also one of the organization’s profitability indicators, although less popular than annual earnings per share. Last quarterly profit Eidos Therapeutics, Inc. for today implies published profit for the last reference quarter. Change in profit Eidos Therapeutics, Inc. for the year is a calculated value for additional information that shows the change in percentage of profit with the same interval of the last year. A change in Eidos Therapeutics, Inc. quarterly profit compared to last year may be significant for companies with a seasonal business. But the main indicator of the company's profitability is the annual change in profit.
For convenience of perception and analysis, we publish the change in profit as a percentage. In the table of the Quarterly Profit service on this page, you can find the history of Eidos Therapeutics, Inc. profit for previous reporting periods, for the last year or other interval. Eidos Therapeutics, Inc. quarterly earnings history is available online for each year and quarter over the past ten years. Eidos Therapeutics, Inc. online profit database for past time intervals is compiled from verified official sources throughout the entire time.
|
